spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

Vaccine Manufacturing

Vaccine Manufacturing

23-25 April 2018
RAI, Amsterdam

Changing the shape of vaccine development, manufacturing and delivery

Vaccine Manufacturing 2018 event will be held 23-25 April 2018 in the RAI Amsterdam – joining the largest Bioprocessing event in Europe – BPI Europe. With 900+ attendees, 275+ companies and 4 days of in-depth programmes in specific fields, this year is one not to be missed!
Don't miss this opportunity to achieve success in vaccine manufacturing by benchmarking with leading industry personalities.

SIGN UP NOW AND SAVE MORE: https://lifesciences.knect365.com/vaccine-manufacturing/?vip_code=CQ3568EBR

Contact:
T: +44 (0) 20 3377 3279
E: LS.Registrations@Knect365.com 

phone +44 (0) 20 3377 3279
email LS.Registrations@Knect365.com
web bit.ly/2sOjJdI
email RAI, Amsterdam
 
Print this page
Send to a friend
   
spacer
Industry Events

BIO-Europe 2018-24th Annual International Partnering Conference

5-7 November 2018, Bella Center Copenhagen, Denmark

The 24th annual BIO-Europe® event is the largest biotechnology partnering conference held in Europe. Over 4,000 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. Business development executives and dealmakers consider BIO-Europe a must-attend event and an effective business strategy enabling them to meet and present to numerous potential partners. BIO-Europe features the industry’s most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward.
More info >>

Banner of PHPL West Coast_events_95 on Samedan Banner of Nordics_Events_97 on Samedan

White Papers

Clinical Trial Site Contracting: The Conservative, Progressive and Hybrid Models

DrugDev

For the last 20 years, pharmaceutical companies have turned to a variety of clinical outsourcing solutions to reduce costs and improve timelines, enabling them to focus on their core value of research and development. In today’s tightly competitive market, companies are constantly striving for ways to further cut costs and reduce study startup cycle times, while maintaining quality. One of the key cost factors in global R&D spending, estimated at around $102 billion per Kalorama market research, is the cost of conducting clinical trials. CRO’s, which account for about 30% of the total R&D spending, have risen to the challenge of the clinical, technical and administrative management of these trials. But some pharmaceutical companies question how much control to relinquish to vendor partners, especially in the legal arena, due to potential ramifications.
More info >>


News and Press Releases

BioIVT Launches Dissociated Tumor Cell DTC Product Line to Advance Oncology Research

Westbury, NY – Sept. 6, 2018 – BioIVT, a leading provider of research models and services for drug development, today announced the addition of a dissociated tumor cell (DTC) product line to its immunology portfolio.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement